Showing results (71-80 of 85) with videos related to
Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2019
Guadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical TrialAnna Maria Di Giacomo, Alessia Covre, Francesca Finotello, et al.Cancer Immunology Research|May 27, 2021
Intracellular Factor H Drives Tumor Progression Independently of the Complement CascadeMarie V Daugan, Margot Revel, Romane Thouenon, et al.Cancer Immunology Research|May 27, 2021
Complement C1s and C4d as Prognostic Biomarkers in Renal Cancer: Emergence of Noncanonical Functions of C1sMarie V Daugan, Margot Revel, Jules Russick, et al.Science Translational Medicine|February 15, 2013
Mucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumorsFederico Sandoval, Magali Terme, Mevyn Nizard, et al.Cancer Research|November 9, 2012
PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancerCécile Badoual, Stéphane Hans, Nathalie Merillon, et al.Blood|September 18, 2008
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndromeVeronique Frémeaux-Bacchi, Elizabeth C Miller, M Kathryn Liszewski, et al.Nature Cancer|February 4, 2022
Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expressionLucile Vanhersecke, Maxime Brunet, Jean-Philippe Guégan, et al.Nature|January 17, 2020
B cells are associated with survival and immunotherapy response in sarcomaFlorent Petitprez, Aurélien de Reyniès, Emily Z Keung, et al.Cancer Immunology Research|June 6, 2019
Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor GrowthLubka T Roumenina, Marie V Daugan, Rémi Noé, et al.Nature Immunology|December 8, 2025
DC subsets and states unraveled across human juxtatumoral and malignant tissuesKevin Mulder, Margaux Gardet, Wan Ting Kong, et al.Pageof 9